BIOETHICS - BIOethics Exploring Trajectories of Health Innovations Challenging Society

Publications 2012 - 2007

Blasimme A, Soulier A, Julia S, Leonard S, Cambon-Thomsen A. Disclosing results to genomic research participants: differences that matter. Am J Bioeth. 2012. 12(10):20-2. doi: 10.1080/15265161.2012.699149. abstract

Mahalatchimy A, Rial-Sebbag E, De Grove-Valdeyron N, Tournay V, Cambon-Thomsen A, Duguet AM, Taboulet FThe European Medicines Agency: a public health European agency ? Med Law. 2012.31(1):25-42.  doi: 10.1111/j.1399-0039.2012.01939.x. abstract

Ruyssen-Witrand A, Constantin A, Cambon-Thomsen A, Thomsen M. New insights into the genetics of immune responses in rheumatoid arthritis. Tissue Antigens. 2012. 80(2):105-18.  doi: 10.1111/j.1399-0039.2012.01939.x. abstract

Kaye J, Meslin EM, Knoppers BM, Juengst ET, Deschênes M, Cambon-Thomsen A, Chalmers D, De Vries J, Edwards K, Hoppe N, Kent A, Adebamowo C, Marshall P, Kato K. Research Priorities. ELSI 2.0 for Genomics and Society. Science.2012.336(6082):673-4.doi: 10.1126/science.1218015 abstract

Rial-Sebbag E, Cambon-Thomsen A. The emergence of biobanks in the legal landscape: towards a new model of governance. J Law Soc. 2012.39(1):113-30. abstract

Boyer JF, Bongard V, Cantagrel A, Jamard B, Gottenberg JE, Mariette X, Davignon JL, Ferrières J, Ruidavets JB, Dallongeville J, Arveiler D, Cambon-Thomsen A, Constantin A. Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: results from a French multicenter cohort. .Arthritis Care Res (Hoboken). 2012.64(6):872-80. doi: 10.1002/acr.21623. abstract

Ducournau P, Gourraud PA, Rial-Sebbag E, Bulle A, Cambon-Thomsen A[Direct-to-consumer genetic testing through Internet: marketing, ethical and social issues]. Med Sci 2011.27(1):95-102. doi: 10.1051/medsci/201127195. abstract

Gourraud PA, Meenagh A, Cambon-Thomsen A, Middleton D. Linkage disequilibrium organization of the human KIR superlocus: implications for KIR data analyses. Immunogenetics. 2010. 62(11-12: 729-40.doi: 10.1007/s00251-010-0478-4. abstract

Ducournau P. Acteurs face à la biopolitique : capacités critiques et tactiques de résistance. Cahiers Internationaux de Sociologie. 2009.127:291-214. abstract

Duguet AM dir. Accès aux transplantations d'organes et de tissus en Europe et droits aux soins en Europe. Les Etudes Hospitalières Bordeaux. 2009.396p. présentation

Barnetche T, Constantin A, Cantagrel A, Cambon-Thomsen A, Gourraud PA. New classification of HLA-DRB1 alleles in rheumatoid arthritis susceptibility: a combined analysis of worldwide samples. Arthritis Res Ther . 2008.10(1):R26.doi: 10.1186/ar2379. abstract

Juillard-Condat B, Constantin A, Cambon-Thomsen A, Bourrel R, Taboulet FImpact of etanercept on the costs of rheumatoid arthritis (RA): results from a French observational study. Joint Bone Spine. 2008 75(1):25-8. abstract

Kauffmann F, Cambon-Thomsen A. Tracing biological collections: between books and clinical trials. JAMA. 2008.299(19):2316-8.doi: 10.1001/jama.299.19.2316. abstract

Rial-Sebbag E. Genèse d'un cadre réglementaire pour les collections d'échantillons biologiques humains utilisées en recherche. 2008.27:233-271. présentation

Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM. Trends in ethical and legal frameworks for the use of human biobanks. Eur Respir J. 2007.30:373-82. abstract

Feve F, Cambon-Thomsen A, Eliaou JF, Gourraud PA, Raffoux C, Florens JP. [Economic evaluation of the organization of a registry of haematopoietic stem cell donors]. Rev Epidémiol Santé Pub. 2007.55(4):275-84. abstract